The deadline for applications in Fenix is Thursday 2nd of October 2025, at 3 p.m.
Page updated 8th of May 2025.
The Swedish Cancer Society, organization number 802005-3370, 101 55 Stockholm, is the body responsible for the collection and processing of personal data in connection with grant applications.
The Swedish Cancer Society has a digitized grant application system called Fenix. Fenix uses BankID and Swedish social security numbers for both identification and signing. The application is signed digitally by both the Head of Department and the applicant directly in Fenix. Applicants sign the application last, i.e. after the Head of Department has signed.
Note that if you make changes to the application after sending it to the Head of Department for signing, you must send a new request for signing by your Head of Department, as the application has changed. This applies regardless of what changes have been made.
Objectives
The grant is intended to facilitate the operation of Graduate Schools aimed at the target group of postgraduate students with projects within the field of cancer.
The Swedish Cancer Society pays research grants only to Swedish universities and higher educational institutions.
Conditions
The Graduate School shall offer the participants postgraduate education within the framework described by the corresponding university or college's postgraduate education committee.
Graduate Schools run jointly by two or more higher education institutions located in different healthcare regions will be given special consideration, as will those that are based on an appropriate balance between clinically and pre-clinically active graduate students.
The support is thus partly intended to encourage cooperation across regional borders and between different higher education institutions with the aim of promoting networking.
It is also the Swedish Cancer Society's intention to stimulate networking between different disciplines. The higher education institutions included in the application must have at least one named applicant.
The application must state the names of the principal applicant and any co-applicants.
Grant period
Graduation School is awarded for a maximum of three years. The grant period can begin between 1st July of the same year in which the decision is made and up to and including 1st January of the year following the decision.
Regardless of the choice of start date, the contract starts from July 1st . Payments are made quarterly, and the first payment is made in September and is retroactive from 1st July the same year as the decision is made.
Use of the grant
Grants can be used for external teachers and lecturers, board and lodging, travel, course administration, course materials and other direct course operation costs. This may include rental costs for lecture halls and the like, but not for the regular premises used by university employees.
The grant may not be used as salary for participating doctoral students. A prerequisite for awarding grants is that there is a budget showing how students' salaries and other expenses are to be covered. In addition the grant is not intended to cover the costs of basic general science courses within the corresponding university's graduate program.
Grants can be awarded up to SEK 800,000 per year.
Every proposal is rigorously evaluated for scientific excellence, clarity, solid methodology, and strong cancer-related relevance in line with the Society’s mission .
Clearly define your role and what you intend to achieve during the grant period.
Highlight your relevant qualifications and past research achievements in the CV and publications list .
For clinical or intervention-based projects, explicitly describe how patients are involved or considered.
A designated box in the application allows you to explain patient engagement or justify its absence .
Swedish universities are the only eligible administering bodies; applications must be approved by both department heads and the applicant via Fenix with BankID
Budgets should cover salaries, overheads (≤ 15%), research costs, and align with funding regulations .
Select the correct funding scheme—Research project, Postdoc, Research months, Junior/Senior Investigator, etc.—based on your career stage and project needs
Note and adhere to the biannual deadlines (spring & fall), with application support for some categories throughout the year
Provide a clear, realistic project schedule with work-plan structure, milestones, and risk awareness.
Particularly for early detection projects, align closely with national goals (e.g., 2030 screening targets)
Applications are peer-reviewed by expert committees across different cancer research fields.
About 1 in 3 proposals receive funding (e.g., 224 out of ~480 in 2023)
Predictor | What You Need to Show |
---|---|
Scientific excellence | Clear, well-designed cancer-focused research |
Role & track record | Defined objectives and strong CV publications |
Patient engagement | Explicit mention or justification in designated box |
Institutional compliance | Fenix/BanKID signatures, budget alignment |
Appropriate scheme & timing | Match grant type and meet deadlines |
Feasibility & innovation | Structured plan with milestones and context |
Peer-review readiness | Strong proposal amid high competition (~30% funding) |
✅ Pro Tips
Attend webinars and review previous calls to understand Society expectations.
Use the patient perspective box effectively to highlight engagement.
Apply to the correct scheme for your career stage and request amount.
Submit early to allow time for institutional approval via Fenix.
Polish your research design and methodology to stand out in peer review.
Eligible to apply are those with a university affiliation and at least associate professor competence.
Eligible Countries:
Sponsor Institute/Organizations: Swedish Cancer Society
Sponsor Type: Corporate/Non-Profit
Address: 101 55 Stockholm Visiting address David Bagares Street 5
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Oct 02, 2025
Oct 02, 2025
$84,186
Affiliation: Swedish Cancer Society
Address: 101 55 Stockholm Visiting address David Bagares Street 5
Website URL: https://www.cancerfonden.se/forskning/for-forskare/sok-anslag-for-forskare/guidelines-graduate-school
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.